Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Riester

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Molecular analysis of a male breast cancer patient with prolonged stable disease under mTOR/PI3K inhibitors BEZ235/everolimusA Rose Brannon, Melissa Frizziero, David Chen, et al.
Database : the Journal of Biological Databases and Curation|April 4, 2013
curatedOvarianData: clinically annotated data for the ovarian cancer transcriptomeBenjamin Frederick Ganzfried, Markus Riester, Benjamin Haibe-Kains, et al.
Plos One|June 4, 2015
Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial TumorsJoaquim Bellmunt, Lillian Werner, Jeffrey J Leow, et al.
Plos Genetics|January 18, 2013
Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severitySubhajyoti De, Rita Shaknovich, Markus Riester, et al.
Journal of the National Cancer Institute|April 5, 2014
Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancerLevi Waldron, Benjamin Haibe-Kains, Aedín C Culhane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2016
Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3Fabrice André, Sara Hurvitz, Angelica Fasolo, et al.
Endocrine-Related Cancer|January 23, 2019
Genomic profiling of NETs: a comprehensive analysis of the RADIANT trialsJames Yao, Abhishek Garg, David Chen, et al.
BMC Cancer|April 18, 2015
DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumorsRichard M Bambury, Ami S Bhatt, Markus Riester, et al.
Nucleic Acids Research|January 28, 2017
Bisulfite-independent analysis of CpG island methylation enables genome-scale stratification of single cellsLin Han, Hua-Jun Wu, Haiying Zhu, et al.
Cancer Research|November 3, 2017
Software for the Integration of Multiomics Experiments in BioconductorMarcel Ramos, Lucas Schiffer, Angela Re, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Molecular analysis of a male breast cancer patient with prolonged stable disease under mTOR/PI3K inhibitors BEZ235/everolimusA Rose Brannon, Melissa Frizziero, David Chen, et al.
Database : the Journal of Biological Databases and Curation|April 4, 2013
curatedOvarianData: clinically annotated data for the ovarian cancer transcriptomeBenjamin Frederick Ganzfried, Markus Riester, Benjamin Haibe-Kains, et al.
Plos One|June 4, 2015
Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial TumorsJoaquim Bellmunt, Lillian Werner, Jeffrey J Leow, et al.
Plos Genetics|January 18, 2013
Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severitySubhajyoti De, Rita Shaknovich, Markus Riester, et al.
Journal of the National Cancer Institute|April 5, 2014
Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancerLevi Waldron, Benjamin Haibe-Kains, Aedín C Culhane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2016
Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3Fabrice André, Sara Hurvitz, Angelica Fasolo, et al.
Endocrine-Related Cancer|January 23, 2019
Genomic profiling of NETs: a comprehensive analysis of the RADIANT trialsJames Yao, Abhishek Garg, David Chen, et al.
BMC Cancer|April 18, 2015
DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumorsRichard M Bambury, Ami S Bhatt, Markus Riester, et al.
Nucleic Acids Research|January 28, 2017
Bisulfite-independent analysis of CpG island methylation enables genome-scale stratification of single cellsLin Han, Hua-Jun Wu, Haiying Zhu, et al.
Cancer Research|November 3, 2017
Software for the Integration of Multiomics Experiments in BioconductorMarcel Ramos, Lucas Schiffer, Angela Re, et al.
Pageof 5